- Investing.com
Market Dynamics | Explore how Corteva navigates competitive pressures in the $50 billion agribusiness sector while balancing innovation investments with margin sustainability challenges |
Analyst Outlook | Barclays maintains an $84 price target with Overweight rating, while earnings projections show upward revisions to $3.59-$3.93 per share range |
Strategic Alliance | The freedom to operate agreement with Bayer unlocks new commercialization pathways, expanding product development flexibility across agricultural technologies |
Growth Trajectory | Corteva demonstrates robust expansion with seed business driving substantial operating earnings growth and management raising full-year guidance |

Metrics to compare | CTVA | Sector Sector - Average of metrics from a broad group of related Basic Materials sector companies | Relationship RelationshipCTVAPeersSector | |
|---|---|---|---|---|
P/E Ratio | 63.0x | 24.8x | 3.8x | |
PEG Ratio | - | 0.50 | 0.00 | |
Price / Book | 0.9x | 1.4x | 1.6x | |
Price / LTM Sales | 1.6x | 1.3x | 1.1x | |
Upside (Analyst Target) | 43.2% | 12.7% | 50.0% | |
Fair Value Upside | Unlock | 2.3% | 5.7% | Unlock |
Corteva, Inc. operates as a pure-play agriculture company in the United States, Canada, the Middle East, Africa, Europe, Latin America, and Asia. The company provides products that protect against weeds, insects, diseases, nematodes, and other pests, as well as supports crop health via nitrogen management and seed-applied technologies. Its crop protection solutions and digital solutions provide farmers tools to improve productivity and help keep fields free of weeds, insects, and diseases. The company offers herbicides, soybeans, cereals, fruits and vegetables, insecticides, nitrogen stabilizers, pasture, and a range management herbicides and biologicals and other nature-based products. The company was incorporated in 2018 and is headquartered in Indianapolis, Indiana.